» Articles » PMID: 6200873

Preferential Masking by the Receptor of Immunoreactive Sites on the Alpha Subunit of Human Choriogonadotropin

Overview
Specialty Science
Date 1983 Dec 1
PMID 6200873
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

125I-Labeled human choriogonadotropin (125I-hCG) bound to rat ovarian receptor was solubilized in Triton X-100. By using increasing concentrations of nine different antisera specific for the individual subunits of human choriogonadotropin (hCG), free 125I-hCG or 125I-hCG-receptor complex was precipitated by double-antibody technique. The ability of any antiserum to bind to the hormone-specific beta subunit was not affected by hCG binding to receptor, suggesting that this subunit is not directly involved with the receptor in the final state of the hormone-receptor complex. In contrast, every antiserum specific for the alpha subunit was dramatically inhibited in binding to the solubilized 125I-hCG-receptor complex. These results suggest that the alpha subunit directly interacts with the receptor, thereby masking immunoreactive sites normally available on the free hormone. Because a number of reports describe binding activity of high concentrations of immunopurified beta subunits of hCG, we propose a two-step model for the binding of hCG to receptor and postulate separate and distinct roles for the subunits. We propose that the binding of hCG to the receptor involves a specific low-affinity initial interaction of the beta subunit with the receptor that activates a second site for the high-affinity binding of alpha subunit and stabilization of the hormone-receptor complex.

Citing Articles

Ovarian failure and autoimmunity. Detection of autoantibodies directed against both the unoccupied luteinizing hormone/human chorionic gonadotropin receptor and the hormone-receptor complex of bovine corpus luteum.

Moncayo H, Moncayo R, Benz R, Wolf A, Lauritzen C J Clin Invest. 1989; 84(6):1857-65.

PMID: 2592563 PMC: 304065. DOI: 10.1172/JCI114372.


Human chorionic gonadotrophin and sport.

Kicman A, Brooks R, Cowan D Br J Sports Med. 1991; 25(2):73-80.

PMID: 1751893 PMC: 1478834. DOI: 10.1136/bjsm.25.2.73.

References
1.
Dufau M, Charreau E, Catt K . Characteristics of a soluble gonadotropin receptor from the rat testis. J Biol Chem. 1973; 248(20):6973-82. View

2.
Pierce J, Bloomfield G, Parsons T . Purification and receptor binding properties of complexes between lutropin and monovalent antibodies against its alpha subunit. Int J Pept Protein Res. 1979; 13(1):54-61. DOI: 10.1111/j.1399-3011.1979.tb01849.x. View

3.
Parsons T, Pierce J . Biologically active covalently cross-linked glycoprotein hormones and the effects of modification of the COOH-terminal region of their alpha subunits. J Biol Chem. 1979; 254(13):6010-5. View

4.
Dighe R, Muralidhar K, Moudgal N . Ability of human chorionic gonadotropin beta-subunit to inhibit the steroidogenic response to lutropin. Biochem J. 1979; 180(3):573-8. PMC: 1161096. DOI: 10.1042/bj1800573. View

5.
Merz W, Dorner M . Studies of the specific role of the subunits of choriogonadotropin for biological, immunological and physical properties of the hormone. Digestion of choriogonadotropin and its isolated subunits with serine carboxypeptidase. Hoppe Seylers Z Physiol Chem. 1979; 360(12):1783-97. DOI: 10.1515/bchm2.1979.360.2.1783. View